BJMO - volume 12, issue 1, february 2018
I. Demeestere
Fertility issues are a major concern for young patients diagnosed with breast cancer. This review focuses on the importance of taking treatment-related ovarian function and fertility decline into consideration by offering appropriate pre-treatment counselling. Fertility preservation options, including oocyte or embryo vitrification, cryopreservation of ovarian tissue, and administration of gonadotropin-releasing hormone analogues should be discussed before starting chemotherapy. We outline the advantages and disadvantages of each technique and review recent data on their efficacy and safety.
(BELG J MED ONCOL 2018;12(1):4–8)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
